Streptozotocin dose-response curve in tilapia, a glucose-responsive teleost fish

James R. Wright, Cherrie Abraham, Brendan C. Dickson, Hua Yang, Carol M. Morrison

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Streptozotocin (STZ) causes β cell necrosis and insulin-dependent diabetes in many species. The specificity of this β cell toxin relates to its structure as an alkylating agent with an attached glucose moiety. STZ uptake by rodent β cells appears to be via the GLUT-2 glucose transporter. Teleost fish, in general, are severely glucose intolerant. The effects of STZ were examined in tilapia, a teleost fish with highly glucose-responsive islets. Fasted tilapia were given 0, 100, 150, 200, 250, 300, or 350 mg/kg STZ iv. Plasma glucose levels were followed for 72 h and the fish autopsied. Histological sections of islets were stained by immunoperoxidase for tilapia insulin. Severe hyperglycemia was seen in 20, 80, and 100% of fish receiving 250, 300, and 350 mg/kg doses; however, sections of islets showed only partial degranulation with no evidence of β cell necrosis. Another group of fish receiving the highest dose were followed longer to determine whether β cell necrosis and permanent hyperglycemia ensued. All fish died or were killed within 9 days because of severe hepatic failure characterized by hepatic necrosis, jaundice, and ascites; islet morphology was relatively normal suggesting, even in a glucose-sensitive species, that fish islets either do not take up STZ or are highly resistant to its 'diabetogenic' effects. Tilapia may thus be a useful model to elucidate mechanisms of action of STZ. Furthermore, STZ may provide important insights into differences in glucose uptake and metabolism by mammalian and piscine β cells.

Original languageEnglish (US)
Pages (from-to)431-440
Number of pages10
JournalGeneral and Comparative Endocrinology
Volume114
Issue number3
DOIs
StatePublished - Jun 1999
Externally publishedYes

Fingerprint

Tilapia
streptozotocin
tilapia (common name)
Streptozocin
dose response
Fishes
Glucose
glucose
fish
necrosis
Necrosis
cells
hyperglycemia
Hyperglycemia
insulin
Insulin
uptake mechanisms
liver failure
glucose transporters
glycemic effect

ASJC Scopus subject areas

  • Endocrinology

Cite this

Streptozotocin dose-response curve in tilapia, a glucose-responsive teleost fish. / Wright, James R.; Abraham, Cherrie; Dickson, Brendan C.; Yang, Hua; Morrison, Carol M.

In: General and Comparative Endocrinology, Vol. 114, No. 3, 06.1999, p. 431-440.

Research output: Contribution to journalArticle

Wright, James R. ; Abraham, Cherrie ; Dickson, Brendan C. ; Yang, Hua ; Morrison, Carol M. / Streptozotocin dose-response curve in tilapia, a glucose-responsive teleost fish. In: General and Comparative Endocrinology. 1999 ; Vol. 114, No. 3. pp. 431-440.
@article{0f42ccacd4a844eda499efb41ae6eca0,
title = "Streptozotocin dose-response curve in tilapia, a glucose-responsive teleost fish",
abstract = "Streptozotocin (STZ) causes β cell necrosis and insulin-dependent diabetes in many species. The specificity of this β cell toxin relates to its structure as an alkylating agent with an attached glucose moiety. STZ uptake by rodent β cells appears to be via the GLUT-2 glucose transporter. Teleost fish, in general, are severely glucose intolerant. The effects of STZ were examined in tilapia, a teleost fish with highly glucose-responsive islets. Fasted tilapia were given 0, 100, 150, 200, 250, 300, or 350 mg/kg STZ iv. Plasma glucose levels were followed for 72 h and the fish autopsied. Histological sections of islets were stained by immunoperoxidase for tilapia insulin. Severe hyperglycemia was seen in 20, 80, and 100{\%} of fish receiving 250, 300, and 350 mg/kg doses; however, sections of islets showed only partial degranulation with no evidence of β cell necrosis. Another group of fish receiving the highest dose were followed longer to determine whether β cell necrosis and permanent hyperglycemia ensued. All fish died or were killed within 9 days because of severe hepatic failure characterized by hepatic necrosis, jaundice, and ascites; islet morphology was relatively normal suggesting, even in a glucose-sensitive species, that fish islets either do not take up STZ or are highly resistant to its 'diabetogenic' effects. Tilapia may thus be a useful model to elucidate mechanisms of action of STZ. Furthermore, STZ may provide important insights into differences in glucose uptake and metabolism by mammalian and piscine β cells.",
author = "Wright, {James R.} and Cherrie Abraham and Dickson, {Brendan C.} and Hua Yang and Morrison, {Carol M.}",
year = "1999",
month = "6",
doi = "10.1006/gcen.1999.7269",
language = "English (US)",
volume = "114",
pages = "431--440",
journal = "General and Comparative Endocrinology",
issn = "0016-6480",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Streptozotocin dose-response curve in tilapia, a glucose-responsive teleost fish

AU - Wright, James R.

AU - Abraham, Cherrie

AU - Dickson, Brendan C.

AU - Yang, Hua

AU - Morrison, Carol M.

PY - 1999/6

Y1 - 1999/6

N2 - Streptozotocin (STZ) causes β cell necrosis and insulin-dependent diabetes in many species. The specificity of this β cell toxin relates to its structure as an alkylating agent with an attached glucose moiety. STZ uptake by rodent β cells appears to be via the GLUT-2 glucose transporter. Teleost fish, in general, are severely glucose intolerant. The effects of STZ were examined in tilapia, a teleost fish with highly glucose-responsive islets. Fasted tilapia were given 0, 100, 150, 200, 250, 300, or 350 mg/kg STZ iv. Plasma glucose levels were followed for 72 h and the fish autopsied. Histological sections of islets were stained by immunoperoxidase for tilapia insulin. Severe hyperglycemia was seen in 20, 80, and 100% of fish receiving 250, 300, and 350 mg/kg doses; however, sections of islets showed only partial degranulation with no evidence of β cell necrosis. Another group of fish receiving the highest dose were followed longer to determine whether β cell necrosis and permanent hyperglycemia ensued. All fish died or were killed within 9 days because of severe hepatic failure characterized by hepatic necrosis, jaundice, and ascites; islet morphology was relatively normal suggesting, even in a glucose-sensitive species, that fish islets either do not take up STZ or are highly resistant to its 'diabetogenic' effects. Tilapia may thus be a useful model to elucidate mechanisms of action of STZ. Furthermore, STZ may provide important insights into differences in glucose uptake and metabolism by mammalian and piscine β cells.

AB - Streptozotocin (STZ) causes β cell necrosis and insulin-dependent diabetes in many species. The specificity of this β cell toxin relates to its structure as an alkylating agent with an attached glucose moiety. STZ uptake by rodent β cells appears to be via the GLUT-2 glucose transporter. Teleost fish, in general, are severely glucose intolerant. The effects of STZ were examined in tilapia, a teleost fish with highly glucose-responsive islets. Fasted tilapia were given 0, 100, 150, 200, 250, 300, or 350 mg/kg STZ iv. Plasma glucose levels were followed for 72 h and the fish autopsied. Histological sections of islets were stained by immunoperoxidase for tilapia insulin. Severe hyperglycemia was seen in 20, 80, and 100% of fish receiving 250, 300, and 350 mg/kg doses; however, sections of islets showed only partial degranulation with no evidence of β cell necrosis. Another group of fish receiving the highest dose were followed longer to determine whether β cell necrosis and permanent hyperglycemia ensued. All fish died or were killed within 9 days because of severe hepatic failure characterized by hepatic necrosis, jaundice, and ascites; islet morphology was relatively normal suggesting, even in a glucose-sensitive species, that fish islets either do not take up STZ or are highly resistant to its 'diabetogenic' effects. Tilapia may thus be a useful model to elucidate mechanisms of action of STZ. Furthermore, STZ may provide important insights into differences in glucose uptake and metabolism by mammalian and piscine β cells.

UR - http://www.scopus.com/inward/record.url?scp=0032995576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032995576&partnerID=8YFLogxK

U2 - 10.1006/gcen.1999.7269

DO - 10.1006/gcen.1999.7269

M3 - Article

C2 - 10336831

AN - SCOPUS:0032995576

VL - 114

SP - 431

EP - 440

JO - General and Comparative Endocrinology

JF - General and Comparative Endocrinology

SN - 0016-6480

IS - 3

ER -